Bryn Mawr Trust CO Adaptive Biotechnologies Corp Transaction History
Bryn Mawr Trust CO
- $5.44 Billion
- Q4 2024
A detailed history of Bryn Mawr Trust CO transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 1,450 shares of ADPT stock, worth $11,368. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,450
Previous 1,450
-0.0%
Holding current value
$11,368
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ADPT
# of Institutions
206Shares Held
142MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$235 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$113 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$91.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$83.4 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.42MShares$73.9 Million0.49% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.12B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...